SITC Cancer Immunotherapy CONNECT

Spring Scientific logo.png

Get Ready for the SITC Spring Scientific

Join our SITC Spring Scientific, Host Immunity in Immunotherapy Responses: From Discoveries to Precision Oncology on March 15-17, 2023 in Denver, CO & Virtual. Early Registration ends March 1 – Save up to $200


Winter School

2023 Advances in Cancer Immunotherapy™ (ACI) Registration is Open

Join your colleagues for an in-depth, clinical education program focused on Intratumoral Therapies, Vaccines & Cytokines – Friday, March 10, 2023 (Houston, TX & Virtual).

Register Today


Open Comment Period for New Gastrointestinal Cancer and Gynecological Cancer Clinical Practice Guidelines

All comments are due to SITC by January 27.

Learn more

SITC CIG App Homescreen Cropped

Download the new SITC Clinical Practice Guidelines Mobile App!
The first and only immunotherapy-specific clinical practice guidelines app featuring expert panel recommendations. Available for FREE for iOS and Android.

Download Now

Target for Cancer IO.png

SITC’s Value Framework for Phase III Immuno-Oncology Trials 

Read the manuscript, “Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer”.


New SITC Clinical Practice Guidelines Published

Includes Acute Leukemia, Breast Cancer, Hepatocellular Carcinoma, Immune Checkpoint Inhibitor-related Adverse Events, Urothelial Cancer, & Nonmelanoma Skin Cancer. Free companion educational webinars available.

Learn more

JITC Anniversary

Celebrate a Decade of Publishing with SITC’s Official Journal

Hear from editors about the state of the field, explore the journal’s major milestones, and read top content.


Attend IO360

Be at the forefront of the most relevant research and developments from key leadership who are at the pulse of cancer immunotherapy at the 9th annual IO360° Summit taking place Feb 7-10 in Brooklyn, NY. 

Register Today


For patients

Explore comprehensive resources and educational opportunities for cancer patients and those who advocate for them.



For Clinicians

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.



For Researchers

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.


Latest Discussions

  • Profile Picture


    Hello, I work at Fred Hutch Cancer Center and we currently have a position for an advanced practice provider in our Phase One Research program. I really enjoy working with this team and the work is very rewarding but also challenging. According to ...

  • I'm sorry it didn't work for you Anna. You can contact them directly through this email address, I'm sure they can figure it out for you. I hope this helps. Regards ------------------------------ Khaoula Mazouzi MD Head of Medical ...

  • Hello Khaoula, thank you for your reply and for attaching the screenshots. I could not overcome the issue. I could not create an account on, I filled my data but the page was not responding. I am not a member of MSKC. Not sure if ...


Follow the SITC Twitter Feed.

Connect with colleagues at these Upcoming Events.

Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders
seeking toadvance research in the cancer immunotherapy field.

Learn More

The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More